Table 1 Baseline characteristics of Type 1 and Type 2 DM patients registered between 2014 and 2019

Sex, Female

300,268 (63.2%)

15,262 (48.1%)

285,006 (64.2%)

Median (IQR) age when diagnosed

57.8 (49.8–65.3)

26.9 (13.4–43.5)

58.5 (51.3–65.8)

  < =18

12,688 (2.7%)

11,562 (36.4%)

1126 (0.3%)

 19–34

17,866 (3.8%)

8646 (27.2%)

9220 (2.1%)

 35–50

103,199 (21.7%)

5798 (18.3%)

97,401 (21.9%)

 51–70

282,678 (59.4%)

4761 (15.0%)

277,917 (62.6%)

  > =71

59,108 (12.4%)

996 (3.1%)

58,112 (13.1%)

 Kazakh

227,611 (47.9%)

14,843 (46.7%)

212,768 (47.9%)

 Russian

137,229 (28.9%)

8057 (25.4%)

129,172 (29.1%)

 Other

107,434 (22.6%)

6899 (21.7%)

100,535 (22.7%)

 Missing

3265 (0.7%)

1964 (6.2%)

1301 (0.3%)

 Median duration of diabetes, years (IQR)

4.5 (2.1–7.9)

4.7 (2.2–8.2)

4.5 (2.1–7.8)

  < 5 years

260,267 (54.7%)

16,882 (53.2%)

243,385 (54.8%)

 5–10 years

140,480 (29.5%)

8750 (27.6%)

131,730 (29.7%)

  > 10 years

74,792 (15.7%)

6131 (19.3%)

68,661 (15.5%)

Dead

64,151 (13.5%)

3581 (11.3%)

60,570 (13.7%)

Median age at death, years (IQR)

70.6 (62.9–78.8)

61.1 (42.6–71.6)

71.0 (63.5–79.0)

 Diabetic neuropathy, yes

27,074 (5.7%)

3626 (11.4%)

23,448 (5.3%)

 Coronary artery disease, yes

88,931 (18.7%)

5223 (16.4%)

83,708 (18.9%)

 Hypertension, yes

203,592 (42.8%)

6890 (21.7%)

196,702 (44.3%)

 Diabetic nephropathy, yes

8118 (1.7%)

1551 (4.9%)

6567 (1.5%)

 Diabetic retinopathy, yes

19,269 (4.0%)

3472 (10.9%)

15,797 (3.6%)

 Stroke, yes

11,846 (2.5%)

888 (2.8%)

10,958 (2.5%)

 Diabetic foot, yes

19,974 (5.4%)

3020 (9.5%)

16,954 (3.8%)

 Amputations, yes

4749 (1.0%)

1156 (3.6%)

3593 (0.8%)

 Neoplasms, yes

27,142 (5.1%)

2274 (7.2%)

21,868 (4.9%)